What is a Good Annual Rate of Return?
Understand how to evaluate investment returns, discount rates, and what realistic expectations look like for long-term value investing.
Should you buy Moderna stock? (NASDAQ:MRNA). Let's see how it does in our automated value investing analysis system.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Moderna to reach your target.
Hmm, we can't give any reliable projection for Moderna's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.
None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!
| Advantages | Disadvantages | Neutral |
|---|---|---|
|
|
|
| MRNA Price (Moderna stock price per share) |
$32.75 | |
| PE Ratio versus Sector | 100% lower than other Healthcare stocks | |
| PE Ratio versus Industry | 100% lower than other Biotechnology stocks |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 69,679,477 shares shorted. With 364,152,373 shares available for purchase and an average trading volume over the past 10 trading days of 11,386,520, it would take at least 6.119 days for all of the short holders to cover their shorts.
Understand how to evaluate investment returns, discount rates, and what realistic expectations look like for long-term value investing.
Learn when dividend yields signal opportunity versus risk, and how to evaluate dividend sustainability in your portfolio.
Master the methods for projecting company growth rates and earnings, essential for calculating intrinsic value with confidence.
Based on our analysis, we believe that you should not buy Moderna right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Advertisement supports free stock analysis content.
Does Moderna have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to MRNA: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
How Much Money Would Change Your Life?
How to Make Money with Penny Stocks
How Do Stock Brokers Make Money?
Why Do Companies Perform Stock Buybacks?
What is a Good Annual Rate of Return?
Stock Brokers and Investment Brokers
Should You Invest in Gold or Silver?